Cargando…
P-130: The impact of COVID-19 on the treatment regimens of myeloma and AL amyloidosis patients
BACKGROUND: As the COVID-19 pandemic unfolded in 2020, Myeloma Patients Europe (MPE) recognized that the pandemic was impacting the healthcare and lives of people with myeloma and AL amyloidosis, and their caregivers. Findings from a small UK study suggested that myeloma patients were more likely to...
Autores principales: | Joyner, Katie, Galinsky, Jayne, Clavreul, Solène |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580178/ http://dx.doi.org/10.1016/S2152-2650(21)02257-6 |
Ejemplares similares
-
P-137: COVID – 19 vaccine uptake in patients with multiple myeloma and AL amyloidosis: a crosssectional observational study from India
por: Ganju, Prabhat, et al.
Publicado: (2022) -
P-147: COVID-19, impact of vaccination in myeloma patients
por: Hoornaert, Ellen, et al.
Publicado: (2021) -
P130: PROVIDING ADEQUATE HEALTHCARE TO PEOPLE WITH HEMOGLOBINOPATHIES DURING THE PANDEMIC (COVID-19)
por: Sophia Delicou, S, et al.
Publicado: (2022) -
Determination of strain pattern in patients with cardiac amyloidosis secondary to Multiple myeloma: a feature tracking study
por: Bhatti, Sabha, et al.
Publicado: (2016) -
P130: Assessment of hand hygiene practices at the two children's hospitals in Greece
por: Kouni, S, et al.
Publicado: (2013)